Used as a key intermediate in the synthesis of pharmaceutical agents targeting central nervous system disorders. The compound shows potential in the development of anxiolytic, anticonvulsant, and antidepressant drugs due to its affinity for various neurotransmitter receptors, including benzodiazepine and serotonin receptors.

Additionally, it is investigated for anti-inflammatory and anticancer properties in preclinical studies. The quinazoline core enables interactions with DNA or inhibition of proteins involved in abnormal cell proliferation, supporting its use in targeted cancer therapies.

Its structural features allow for chemical modifications to enhance bioavailability and selectivity. In biochemical research, it serves as a tool for studying intracellular signaling pathways related to inflammation and apoptosis, deepening understanding of disease mechanisms.